Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
oj...
Our stock cannot be sold until approved..So it is included as money spent on manufacturing costs
not as an asset.... You really do not have a clue in how to understand accounts....We are funded
for the next 12 months.. Our accounts are audited so anyone who wants to go through
them in detail can see all expenditure...Nothing is being hidden ..... !!!
Not apologising for being wrong about our stock levels then???
Man, thats even funnier...if you believe the '10's of thousands ' of doses existed on the 31st December. then you are still NOT asking the question where 7-8Million disappeared from accounts in early spring...hilarious!!
oj17
Our Spring accounts have not been published so you are making up very serious
allegations in implying funds have "disappeared"...... You need to be very careful..
I am reporting you !!!!
Man,
get real, its public knowledge.
31Dec21 Accounts state 33.8M cash in hand
17 Feb 22 RNS 'in excess of 25M'
so if you believe inventory 0 means '10s of thousands of doses' where did the 8 million disappear to?
oj17
You cannot discuss accounts you have not seen...You are
making up defamatory points to suit your agenda..... I
am not responding to you any further.. I have reported you and
trust Admin will deal with the matter!
OMg - these are statements that SNG have on their website - take the time to look. Is typical that anybody who criticizes the BOD or questions how money is spent ( or not spent) is a deramper.. get your head out of sand and go look at accounts of 31 December which state 0 Liabilities and then look at the RNS of 17 Feb... its black and white...
Gunto2022 has already been unmasked as a sockpuppet. oj17's writing style is reminiscent of someone. Wasn't he unmasked as a sockpuppet recently?
Some people on here are ignorant as they do not even know how these grant of options work.
They are just using this to try and trade a 10% profit.
Jeez Get a Grip!!!!
Aether I called you out a couple of weeks ago for the continuous building of a narrative to oust management. Well it failed pretty miserably didn’t it?!
Aether not to be trusted. Plays a subtle game but in the end, a failure.
Socketpuppet.
Green bin it.
Don't feed it.
It's probably Rob/Org/Andy. There's a shrill unhinged quality to it's writing.
My writing style is actually more akin to a cotton sock: breathable and strong.
Org is the easiest poster to spot. He is currently wandering the near empty halls of ADFVN, posting correspondence from his NIH contact on a public forum and barely understanding the content.
As for Andy, they revealed themselves to be a trader. An antisocial one, true. But also a well researched one. Suddenly reappeared on the first mention online of STRIVE.
Truth be told I don’t really care who you are, Aether. You post a lot here and if it makes you happy, fair play.
Wigster77's comment from 21:30 last Thursday is where the "tens of thousands of doses of active treatment and placebo" came from. I believe he was one of the posters here who attended last week's AGM.
Yes, the BOD were very clear with their answer. 10’s of thousands of doses ready and waiting.
3 different buys of 50,000 shares a time this afternoon, seems very precise and in quick succession to be a PI. Someone’s taking chunks.
Hi Palladin - I came out of the meeting feeling extremely positive.
I was, like most people, extremely disappointed by the Sprinter results, but after the initial shock decided to take a more pragmatic view rather than demanding heads on pikes like some people did. However, I didnt travel over 100 miles to get fobbed off by flannel. We put forward some very direct, probing and difficult questions (many of which were thanks to members on here) and none were dodged and all answers seemed genuine. Not all members of the board were amazingly eloquent, but this was largely the ones with "backroom" roles rather than customer-facing roles.
Commercialisation was talked about, both in terms of likelihood and timelines and it was clear that this is their primary objective - however it will take time. Someone asked directly whether this would take place within the next 12 months and Simon Shaw (if memory serves) stated "highly unlikely". Realistic rather than the answer we wanted to hear.
I guess my positivity was mostly cemented by the chats with Sir Stephen Holgate, Richard Marsden and Dr. Bruce Campbell after the meeting. The main point I took away is that these guys are extremely passionate about the product and its usefulness and need on the world stage. They say they are working "at haste" - hopefully they are...we have no way of knowing for certain - but one thing was clear: they're not going to rush this for a quick buck. They know they need to build a formidable, robust case for SNG001 to maximimise it's commercial value. They were all very calm and the belief in the product shone through. Dr. Bruce Campbell particularly cited an example of a similar process he'd been involved with previously at another pharma where trial results and market caps were up and down like a yoyo and there was a calm "I've been doing this for years...SNG001 will come good" air in his comments.
So, that's my take, my personal view, based on my assessment of what I saw. I'd love to hear the views of other attendees - you may well get a totally different viewpoint. As I said, I'm probably more on the pragmatic end of the scale, but I was closely watching HOW they answered the questions as well as the content of the answers and it all seemed genuine to me, hence me leaving feeling very positive.
DYOR & GLA!